Search
Azenta Inc
AZTAAdd to Watchlist
26.060USD
-0.130-0.50%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.20BMarket Cap
LossP/E TTM
More Details of Azenta Inc Company
Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Azenta Inc Info
Ticker SymbolAZTA
Company nameAzenta Inc
IPO dateFeb 02, 1995
CEOMarotta (John)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endFeb 02
Address200 Summit Drive
CityBURLINGTON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01803
Phone19782622400
Websitehttps://www.azenta.com/
Ticker SymbolAZTA
IPO dateFeb 02, 1995
CEOMarotta (John)
Company Executives of Azenta Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Ephraim Starr
Mr. Ephraim Starr
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
68.39K
-5.29%
Ms. Robyn C. Davis
Ms. Robyn C. Davis
Independent Director
Independent Director
40.63K
+17.24%
Mr. John Marotta
Mr. John Marotta
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
38.07K
-234.40%
Mr. Lawrence Y Lin
Mr. Lawrence Y Lin
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
24.73K
-222.14%
Mr. Alan J. Malus
Mr. Alan J. Malus
Independent Director
Independent Director
17.04K
--
Dr. Ginger Zhou
Dr. Ginger Zhou
Senior Vice President, General Manager - Multi-Omics
Senior Vice President, General Manager - Multi-Omics
12.55K
-67.32%
Mr. Quentin Koffey
Mr. Quentin Koffey
Independent Director
Independent Director
10.70K
+52.94%
Ms. Olga Pirogova
Ms. Olga Pirogova
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
5.52K
-498.08%
Ms. Erica J. Mclaughlin, CPA
Ms. Erica J. Mclaughlin, CPA
Independent Director
Independent Director
--
--
Mr. Frank E. Casal
Mr. Frank E. Casal
Independent Chairman of the Board
Independent Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ephraim Starr
Mr. Ephraim Starr
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
68.39K
-5.29%
Ms. Robyn C. Davis
Ms. Robyn C. Davis
Independent Director
Independent Director
40.63K
+17.24%
Mr. John Marotta
Mr. John Marotta
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
38.07K
-234.40%
Mr. Lawrence Y Lin
Mr. Lawrence Y Lin
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
24.73K
-222.14%
Mr. Alan J. Malus
Mr. Alan J. Malus
Independent Director
Independent Director
17.04K
--
Dr. Ginger Zhou
Dr. Ginger Zhou
Senior Vice President, General Manager - Multi-Omics
Senior Vice President, General Manager - Multi-Omics
12.55K
-67.32%
FAQs
Who are the top five shareholders of Azenta Inc?
The top five shareholders of Azenta Inc are: Mr. Ephraim Starr
How many institutions hold shares of Azenta Inc (AZTA)?
As of 2026Q1, 683 institutions hold shares of Azenta Inc, with a combined market value of approximately 52.28M, accounting for 113.43% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -4867245.00.